MedPath

Sulfasalazine

SULFASALAZINE TABLETS, USP

Approved
Approval ID

2fc8c918-157c-4898-9b26-80d9ae2fc143

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 1, 2014

Manufacturers
FDA

Aidarex Pharmaceuticals LLC

DUNS: 801503249

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sulfasalazine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code33261-756
Application NumberANDA040349
Product Classification
M
Marketing Category
C73584
G
Generic Name
sulfasalazine
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 1, 2014
FDA Product Classification

INGREDIENTS (7)

SULFASALAZINEActive
Quantity: 500 mg in 1 1
Code: 3XC8GUZ6CB
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sulfasalazine - FDA Drug Approval Details